CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-17 | Luly Jay R. President and CEO | Sale | −10,968 | $105.83 | $1.2M | 628,026 |
| 2018-05-16 | Luly Jay R. President and CEO | Sale | −14,032 | $105.82 | $1.5M | 638,994 |
| 2018-05-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion | +2,955 | $43.46 | $128K | 8,955 |
| 2018-05-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −400 | $103.85 | $42K | 8,555 |
| 2018-05-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −800 | $104.81 | $84K | 7,755 |
| 2018-05-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,955 | $105.57 | $312K | 4,800 |
| 2018-05-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,955 | 84,090 | ||
| 2018-04-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion | +2,955 | $43.46 | $128K | 10,225 |
| 2018-04-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,800 | $85.11 | $153K | 8,425 |
| 2018-04-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,425 | $85.92 | $208K | 6,000 |
| 2018-04-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,955 | 87,045 | ||
| 2018-03-19 | MELLETT PAUL J Treasurer and CFO | Sale | −1,000 | $85.05 | $85K | 96,458 |
| 2018-03-19 | MELLETT PAUL J Treasurer and CFO | Sale | −3,900 | $86.00 | $335K | 92,558 |
| 2018-03-19 | MELLETT PAUL J Treasurer and CFO | Sale | −3,900 | $87.25 | $340K | 88,658 |
| 2018-03-19 | MELLETT PAUL J Treasurer and CFO | Sale | −200 | $87.94 | $18K | 88,458 |
| 2018-02-28 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2018-02-28 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2018-02-28 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +3,750 | 3,750 | ||
| 2018-02-28 | Golumbeski George Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2018-02-28 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 |
Page 29 of 31 · 619 trades